sponsorship: SD has served as a speaker, consultant, and advisory board member for Schering-Plough, Abbott Laboratories, Merck, UCB-pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Danone, Alpha Wasserman, Genentech, Grunenthal, Pfizer, Astra Zeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor, and Johnson & Johnson. GF served as a consultant and advisory board member for MSD, AbbVie, Takeda, Janssen, Mundipharma, Sandoz, Pfizer, Samsung Bioepis, Celltrion. TR has served as a speaker/or advisory board member for Abbvie, Astellas, Dr Falk, GSK, Janssen, MSD, Takeda. JK has served as a speaker and/or advisory board member for AbbVie, Celltrion, EGIS, Kyowa Hakko Kirin Pharma, MSD, Takeda. LPL has served as a speaker and/or advisory board member for AbbVie, Celltrion, EGIS, Falk Pharma GmbH, Ferring, Genentech, Hospira, Kyowa Hakko Kirin Pharma, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, Pharmacosmos, Pfizer, Roche and Takeda, and received unrestricted research grants from AbbVie, MSD, Pfizer/Hospira. GJM has received honoraria for lectures, consultations, advisory boards and clinical trials from AbbVie, Amgen, Angelini, Astellas, Astra-Zeneca, Danone, Falk Pharma, Ferring, GSK, Hoffann-La Roche, Hospira, Janssen, Menarini, Millenium, MSD, OMEGA Pharma, Otsuka, Pharmacosmos, Pfizer, Sandoz, Takeda. LPB has received honoraria from Merck, Abbvie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Hospira/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC-Pharma, Index Pharmaceuticals, Amgen, Sandoz, Forward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis. MF has received a research grant from Takeda; Speakers fees from Abbvie, Boehringer-Ingelheim, Chiesi, Falk, Ferring, Janssen, Mitsubishi Tanabe, MSD, Takeda, Tillotts, Zeria; Consultancy fees from: Abbvie, Boehringer-Ingelheim, Ferring, Janssen, MSD. (AbbVie, MSD, Pfizer/Hospira, Takeda, Boehringer-Ingelheim, Chiesi, Falk, Ferring, Janssen, Mitsubishi Tanabe, Tillotts, Zeria)
No takes yet. Share an insight, caveat, or question.
Danese et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: